Synovus Financial’s Armata Pharmaceuticals ARMP Stock Holding History

Synovus Financial’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,903	Closed	-$202K	–	862
2022 Q3	$202K	Hold	47,903	–	–	﹤0.01%	789
2022 Q2	$187K	Hold	47,903	–	–	﹤0.01%	809
2022 Q1	$235K	Sell	47,903 -132	-0.3%	-$676	﹤0.01%	785
2021 Q4	$263K	Sell	48,035 -25	-0.1%	-$105	﹤0.01%	773
2021 Q3	$174K	Buy	48,060 +25,000	+108%	+$95.2K	﹤0.01%	812
2021 Q2	$91K	Buy	+23,060	New	+$97K	﹤0.01%	825
2018 Q4	–	Sell	-1,071	Closed	-$15K	–	1391
2018 Q3	$15K	Hold	1,071	–	–	﹤0.01%	1055
2018 Q2	$17K	Hold	1,071	–	–	﹤0.01%	969
2018 Q1	$16K	Hold	1,071	–	–	﹤0.01%	965
2017 Q4	$15K	Hold	1,071	–	–	﹤0.01%	575
2017 Q3	$14K	Hold	1,071	–	–	﹤0.01%	571
2017 Q2	$12K	Buy	1,071 +892	+498%	+$21.6K	﹤0.01%	727
2017 Q1	$11K	Buy	179 +100	+127%	+$6.79K	﹤0.01%	934
2016 Q4	$5K	Buy	+79	New	+$9.82K	﹤0.01%	972

Other funds holding ARMP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Synovus Financial's ARMP Position: Q4 2022 in Review

Synovus Financial sold out of Armata Pharmaceuticals (ARMP) in Q4 2022, closing a stake of 47,903 shares — an estimated $202K sold.

Synovus Financial first reported a position in ARMP in Q4 2016 and held it in 14 quarters. The position peaked at $263K in Q4 2021. 26 funds tracked by Wall St. Rank hold ARMP as of Q4 2022.

Synovus Financial reported no remaining Armata Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Synovus Financial sold 47,903 Armata Pharmaceuticals shares in Q4 2022, an estimated $202K.
Synovus Financial first reported a position in Armata Pharmaceuticals in Q4 2016 and held it in 14 quarters.
Synovus Financial's Armata Pharmaceuticals position peaked at $263K in Q4 2021.
26 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2022.

Based on Synovus Financial's 13F filing for Q4 2022, filed 6 Feb 2023.